Vascular Neurology Considerations for Anti-Amyloid Immunotherapy
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of member benefits, join or renew today.
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Authors Mark Fisher, MD and Steve Greenberg, MD announce the publication of the science advisory in the journal STROKE and discuss predictors of ARIA, the use of antithrombotic and thrombolytic medications in patients receiving anti-amyloid therapy, and suggested treatment approaches.
Recommended Videos
Key Diagnostic Points from the Kawasaki Disease Statement
Future Directions of Kawasaki Disease
Advancements in the Treatment of Kawasaki Disease
Acute and Long Term Imaging Management for Kawasaki Disease
Updates on Echocardiograms for Measurements of the Coronary Artery in Pati...
Loading...
Save Video
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.